CytoDyn Inc. (CYDY)
OTCMKTS: CYDY · Delayed Price · USD
0.139
+0.001 (1.02%)
Jul 2, 2024, 3:55 PM EDT - Market closed
CytoDyn Market Cap
CytoDyn has a market cap or net worth of $147.14 million as of July 2, 2024. Its market cap has decreased by -40.61% in one year.
Market Cap
147.14M
Enterprise Value
176.22M
1-Year Change
-40.61%
Ranking
n/a
Category
Stock Price
$0.14
Market Cap Chart
Since July 3, 2019, CytoDyn's market cap has decreased from $181.30M to $147.14M, a decrease of -18.84%. That is a compound annual growth rate of -4.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 135.15M | -25.26% |
| Dec 29, 2023 | 180.83M | -3.43% |
| Dec 30, 2022 | 187.25M | -72.81% |
| Dec 31, 2021 | 688.66M | -77.89% |
| Dec 31, 2020 | 3.11B | 620.79% |
| Dec 31, 2019 | 432.11M | 138.34% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 860.48B |
| Novo Nordisk | 629.27B |
| UnitedHealth Group | 468.72B |
| Johnson & Johnson | 351.76B |
| Merck & Co. | 313.56B |
| AbbVie | 302.88B |
| AstraZeneca | 241.81B |
| Thermo Fisher | 211.09B |